skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Toxicovigilance: A new approach for the hazard identification and risk assessment of toxicants in human beings

Journal Article · · Toxicology and Applied Pharmacology
 [1];  [1]
  1. Centre Antipoison-Centre de Pharmacovigilance, 162 Avenue Lacassagne, 69424 Lyon cedex 03 (France)

The concept of toxicovigilance encompasses the active detection, validation and follow-up of clinical adverse events related to toxic exposures in human beings. Poison centers are key players in this function as poisoning statistics are essential to define the cause, incidence and severity of poisonings occurring in the general population. In addition, the systematic search for unexpected shifts in the recorded causes of poisonings, e.g., following the introduction of a new product, or change in the formulation or recommended use of an old product, allows for a rapid detection of potential adverse health consequences and the implementation of preventive or corrective measures. However, toxicovigilance is genuinely a medical and not only a statistical approach of human toxicity issues. In contrast to epidemiology, toxicovigilance is based on the in-depth medical assessment of acute or chronic intoxications on an individual basis, which requires detailed information that poison centers can rarely obtain via emergency telephone calls and that epidemiologists cannot collect or process. Validation of this medical information must primarily be based on toxicological expertise to help identify causal links between otherwise unexplained pathological conditions and documented toxic exposures. Thus, toxicovigilance can contribute to hazard identification and risk assessment by providing medically validated data which are often overlooked in the process of risk assessment. So far, very few structured toxicovigilance systems have been set up and hopefully national and international initiatives will bridge this gap in our knowledge of the toxicity of many chemicals and commercial products in human beings.

OSTI ID:
20721965
Journal Information:
Toxicology and Applied Pharmacology, Vol. 207, Issue 2,suppl.1; Conference: ICT X 2004: 10. international congress of toxicology: Living in a safe chemical world, Tampere (Finland), 11-15 Jul 2004; Other Information: DOI: 10.1016/j.taap.2005.02.019; PII: S0041-008X(05)00236-X; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Priority setting for risk assessment-The benefit of human experience
Journal Article · Thu Sep 01 00:00:00 EDT 2005 · Toxicology and Applied Pharmacology · OSTI ID:20721965

Nuisance Odors: Is there a Concern - 12340
Conference · Sun Jul 01 00:00:00 EDT 2012 · OSTI ID:20721965

Nanotechnology in agriculture: Opportunities, toxicological implications, and occupational risks
Journal Article · Tue Aug 15 00:00:00 EDT 2017 · Toxicology and Applied Pharmacology · OSTI ID:20721965